Although the pathogenic relevance of the p53 tumor suppressor pathway in the etiology of melanoma is debated, recently published data show that p53 is functionally inactivated in about 65% of melanomas by elevated expression of MDM4. Here, we set out to elucidate the mechanisms that underlie MDM4 upregulation by identifying MDM4 associated partners in melanoma using immunoaffinity purification.